Health in Jamaica 1,268 indicators covering health for Jamaica. IndicatorLatest Year10-yr change Rank 3.1.1 Maternal mortality ratio 99 2020 up 12.9% 69th Low birth weight prevalence 13.7% 2020 down 5.5% 42nd Inactivated first-dose polio vaccine (IPV1) immunization coverage 95.0% 2025 up 187.9% 78th Low birth weight number 4.6 2020 down 24.6% 107th Number of new hivaids infections who 1,100 2024 down 15.4% 74th Reported rabies deaths 0 2021 — 61st Number of current cigarette smokers, estimate 163,000 2030 down 16.8% 133rd 2.2.2a Prevalence of overweight among children under 5 5.7 2022 down 17.4% 77th 2.2.1 Prevalence of stunting among children under 5 6.5 2022 up 6.6% 122nd Reported number of children receiving antiretroviral therapy 125 2025 down 57.0% 75th Concentrations of fine particulate matter 12.66 2023 down 24.1% 125th Death rate road traffic injuries 15.1 2019 up 32.5% 94th New or unknown treatment history cases: Pulmonary, bacteriologically 78 2023 up 32.2% 162nd Constant stillbirth rate 13.71 2030 unchanged 52nd ENAP target met stillbirth rate 12 2030 down 10.8% 1st Stillbirth rate high-income country 2.8 2030 down 74.4% 1st Stillbirths remain constant projection 407 2030 down 10.0% 118th Stillbirth maintained projection 373 2030 down 16.4% 117th Stillbirth ENAP 2030 target met projection 355 2030 down 19.9% 116th Stillbirth high-income country average rate matched projection 82 2030 down 77.2% 139th Stillbirth rate current trends 12.57 2030 down 7.2% 49th Life satisfaction vs life expectancy 71.48 2023 down 1.3% 152nd Estimate of current cigarette smoking prevalence 7.7% 2030 down 16.3% 113th Estimate of current cigarette smoking prevalence (%) 7.6% 2030 down 18.3% 115th Tb patients tested positive for hiv 8 2021 down 52.9% 126th Number of children aged 6-59 months with anaemia 54.95 2019 down 11.3% 134th Prevalence of anaemia in children aged 6-59 months 23.6% 2019 down 11.3% 114th Number of deaths attributed to non-communicable diseases, by type of 4,570 2019 up 10.0% 122nd Hepatitis B surface antigen (HBsAg) prevalence 0.2% 2024 down 33.3% 82nd Mean hemoglobin level of children aged 6-59 months 118 2019 up 0.9% 74th Estimated number of MDR/RR-TB incident cases 1 2024 unchanged 168th Neonatal mortality rate - Remains constant 13.65 2030 unchanged 63rd Neonatal mortality rate - Current trends maintained 13.24 2030 down 2.5% 60th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 73.3% 1st Neonatal mortality rate - SDG target met 12 2030 down 10.2% 1st Under 5 mortality rate - Remains constant 17.79 2030 unchanged 81st Under 5 mortality rate - Current trends maintained 17.2 2030 down 2.8% 77th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 64.2% 1st Under 5 mortality rate - SDG target met 15.97 2030 down 8.6% 80th Mortality rate age 10-19 - Remains constant 5.91 2030 down 0.5% 80th Mortality rate age 10-19 - Current trends maintained 5.84 2030 down 1.5% 70th Mortality rate age 10-19 - High-income country average rate matched 4.13 2030 down 24.3% 68th Neonatal deaths - Remains constant 400 2030 down 8.0% 116th Neonatal deaths - Current trends maintained 388 2030 down 10.4% 114th Neonatal deaths - SDG target met 351 2030 down 17.6% 113th Under-five deaths - Remains constant 526 2030 down 8.2% 121st Under-five deaths - Current trends maintained 508 2030 down 10.7% 121st Under-five deaths - SDG target met 472 2030 down 16.0% 121st Deaths age 10 to 19 - Remains constant 214 2030 down 14.1% 121st Deaths age 10 to 19 - Current trends maintained 210 2030 down 15.3% 121st Mortality caused by road traffic injury 15.1 per 100,000 population 2019 up 18.9% 94th Mortality caused by road traffic injury, female 8.9 per 100,000 female population 2019 up 45.9% 76th Mortality caused by road traffic injury, male 21.3 per 100,000 male population 2019 up 9.8% 101st Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Ipv vaccine coverage 94 2024 up 184.8% 90th Tb patients living with hiv receiving art 8 2021 down 42.9% 114th HIV-positive TB patients on ART (antiretroviral therapy) 83.0% 2024 down 12.6% 110th Hospital beds 16.47 2023 down 2.0% 103rd New leprosy case detection rate per 1 000 000 population 0.352 2024 — 104th Treatment success rate: HIV-positive TB cases 38 2023 down 53.1% 142nd ← Previous Page 17 of 22 Next →